[PAR] YoY Annual Result on 30-Jun-2019 [#FY]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#FY]
Profit Trend
YoY- -152.47%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Annual Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 79 21 0 2,984 2,683 1,823 1,291 -37.21%
PBT -47,012 -42,646 -15,947 -18,611 -8,873 -6,099 -4,215 49.44%
Tax -7,763 -8,349 -3,648 -2,984 -2,683 -1,823 -1,291 34.83%
NP -39,250 -34,297 -12,299 -15,628 -6,190 -4,275 -2,924 54.13%
Tax Rate - - - - - - - -
Total Cost 39,329 34,318 12,299 18,611 8,873 6,099 4,215 45.07%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -49,542.54 -166,896.27 0.00 -523.73 -230.76 -234.49 -226.60 145.34%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.16 -0.16 -0.06 -0.11 -0.05 -0.04 -0.03 32.16%
EPS Diluted -0.16 -0.16 -0.06 -0.11 -0.05 -0.04 -0.03 32.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.